Abstract
A 69-year-old woman with axial and peripheral spondyloarthritis (diagnosed in 2016) was in remission on anti-tumour necrosis factor therapy (adalimumab 40 mg every other week). She presented to our rheumatology unit with a 3-month history of inflammatory back pain and polyarthralgia associated with morning stiffness lasting more than 1 h.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
